A Michigan University-led international team of researchers has developed a new gene-editing tool 'CRISPR-Cas3' which can edit longer parts of the DNA. The tool can help determine what large areas of DNA are most important for a particular disease, researchers said. However, scientists claimed the technique will take years before it is ready for any therapeutic use.